Cite

    Randy Strong et al.. “Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer.” Aging cell, vol. 15, no. 5, 2016, pp. 872–884. http://access.bl.uk/ark:/81055/vdc_100035842512.0x00002a